These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 22331262)
1. Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism. Vauquelin G; Bostoen S; Vanderheyden P; Seeman P Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):337-72. PubMed ID: 22331262 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Seeman P; Tallerico T Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836 [TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
4. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Kapur S; Seeman P Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973 [TBL] [Abstract][Full Text] [Related]
5. A new framework for investigating antipsychotic action in humans: lessons from PET imaging. Kapur S Mol Psychiatry; 1998 Mar; 3(2):135-40. PubMed ID: 9577837 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia. Langlois X; Megens A; Lavreysen H; Atack J; Cik M; te Riele P; Peeters L; Wouters R; Vermeire J; Hendrickx H; Macdonald G; De Bruyn M J Pharmacol Exp Ther; 2012 Jul; 342(1):91-105. PubMed ID: 22490380 [TBL] [Abstract][Full Text] [Related]
7. The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor. Sahlholm K; Zeberg H; Nilsson J; Ögren SO; Fuxe K; Århem P Eur Neuropsychopharmacol; 2016 Mar; 26(3):467-76. PubMed ID: 26811292 [TBL] [Abstract][Full Text] [Related]
8. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Seeman P; Corbett R; Van Tol HH Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795 [TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Wilson JM; Sanyal S; Van Tol HH Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018 [TBL] [Abstract][Full Text] [Related]
10. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Xiberas X; Martinot JL; Mallet L; Artiges E; Loc'H C; Mazière B; Paillère-Martinot ML Br J Psychiatry; 2001 Dec; 179():503-8. PubMed ID: 11731352 [TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol. Markianos M; Hatzimanolis J; Lykouras L Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576 [TBL] [Abstract][Full Text] [Related]
12. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049 [TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Kapur S; Remington G Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792 [TBL] [Abstract][Full Text] [Related]
14. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms. Goudie AJ; Baker LE; Smith JA; Prus AJ; Svensson KA; Cortes-Burgos LA; Wong EH; Haadsma-Svensson S Behav Pharmacol; 2001 Sep; 12(5):303-15. PubMed ID: 11710745 [TBL] [Abstract][Full Text] [Related]
16. Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity. Ogren SO; Ferré S; Schwarcz R; Fuxe K Neurosci Lett; 1997 Aug; 232(1):21-4. PubMed ID: 9292882 [TBL] [Abstract][Full Text] [Related]
17. Slow dissociation of partial agonists from the D₂ receptor is linked to reduced prolactin release. Carboni L; Negri M; Michielin F; Bertani S; Fratte SD; Oliosi B; Cavanni P Int J Neuropsychopharmacol; 2012 Jun; 15(5):645-56. PubMed ID: 21733233 [TBL] [Abstract][Full Text] [Related]
18. Partial agonism and fast dissociation of LASSBio-579 at dopamine D2 receptor. Pompeu TE; Monteiro do Monte F; Bosier B; Fraga CA; Barreiro EJ; Menegatti R; Hermans E; Noël F Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():1-6. PubMed ID: 25891249 [TBL] [Abstract][Full Text] [Related]
19. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
20. "Hit-and-run" actions at dopamine receptors, part 1: Mechanism of action of atypical antipsychotics. Stahl SM J Clin Psychiatry; 2001 Sep; 62(9):670-1. PubMed ID: 11681760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]